Results 231 to 240 of about 164,986 (311)

Sudden unexpected infant death, sudden unexplained death in childhood, and sudden unexpected death in epilepsy

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
Abstract Sudden deaths in infants and children represent a profound and tragic event that continues to challenge researchers despite extensive investigation over several decades. The predominant phenotype, sudden infant death syndrome (SIDS), has evolved into the broader category of sudden unexpected infant death (SUID).
Suvasini Sharma   +3 more
wiley   +1 more source

Wearable sensors in paediatric neurology

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
Types of signals monitored in children's natural environments using wearable sensors, and their associated applications in various paediatric neurological conditions. Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16267 Abstract Wearable sensors have the potential to transform diagnosis, monitoring, and management of children ...
Camila González Barral, Laurent Servais
wiley   +1 more source

Association between sleep duration and obesity in patients with type 2 diabetes: A longitudinal study

open access: yesDiabetic Medicine, EarlyView.
Abstract Background Obesity is prevalent in patients with type 2 diabetes (T2D) and negatively impacts diabetes outcomes. While studies in the general population have established a link between sleep duration and obesity, this relationship in T2D remains unclear. Objectives To assess the association between sleep duration and adiposity in patients with
Esraa A. Makhdom   +22 more
wiley   +1 more source

Use of semaglutide and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To investigate the putative association between semaglutide and non‐arteritic anterior ischaemic optic neuropathy (NAION). Materials and Methods Data from national health registries in Denmark (2018–2024) and Norway (2018–2022) were used to compare NAION risk in individuals with type 2 diabetes initiating semaglutide versus sodium‐glucose
Emma Simonsen   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy